

The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
According to the latest report by IMARC Group, titled “ Hybrid Operating Room Market: Global Industry Trends, Share, Size, Growth, Opportunity and Foreca st 2022-2027
” the global hybrid operating room market reached a strong growth in 2021.
A hybrid operating room (HOR) is a surgical workspace that combines a traditional operating theatre with advanced medical imaging capabilities. It includes angiography, computed tomography (CT), magnetic resonance imaging (MRI), and other intraoperative diagnostic imaging systems. Hybrid operating rooms are widely used for minimally invasive (MI) surgeries, high-quality interventional imaging, and highly complex open surgical procedures. It assists clinicians in diagnosing and treating patients in a single location while improving efficiency, minimizing risks, enhancing patient safety, and reducing operating costs. As a result, it is extensively used for neurological, cardiovascular, thoracic, and orthopedic surgeries.
Request Free Sample Report: https://www.imarcgroup.com/hybrid-operating-room-market/requestsample
The global HOR market is primarily being driven by the increasing demand for MI surgeries due to faster recovery time, decreased post-surgery complications, and minimal scarring. Furthermore, the rising geriatric population and the increasing prevalence of chronic and lifestyle diseases, such as neurological and cardiovascular diseases (CVDs), are acting as other growth-inducing factors. Additionally, the integration of augmented reality (AR) to assist the operator with three-dimensional (3D) images of a patient’s anatomy for precise treatment is providing an impetus to market growth. Moreover, the utilization of artificial intelligence (AI) in software systems to optimize procedure selection and preparation and set radiation exposure in scanning applications is creating a positive outlook for market growth. Other factors, including rising investments in improving medical infrastructures, increasing expenditure capacities of consumers, recent technological advancements in robotics, and extensive research and development (R&D) activities, are anticipated to drive the market toward growth.
Looking forward, the market value is projected to reach a strong growth during the forecast period (2022-2027).
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.